ACE inhibitor angioedema: characterization and treatment versus non-ACE angioedema in acute hospitalized patients

ACE inhibitor angioedema: characterization and treatment versus non-ACE angioedema in acute hospitalized patients

Background ACE angioedema has not been characterized in comparison with angioedema from other causes in acute hospitalized patients. Methods We retrospectively compared ACE-angioedema and non-ACE angioedema patients from January 2013 to May 2017. Results Of 855 cases screened, 575 met the inclusion...

Full description

Bibliographic Details
Main Authors:	David S. Weisman, Nelly Arnouk, M. Bilal Asghar, M. Raheel Qureshi, Anagha Kumar, Sameer Desale, Lyn Camire, Stephen Pineda
Format:	Article
Language:	English
Published:	Greater Baltimore Medical Center 2020-01-01
Series:	Journal of Community Hospital Internal Medicine Perspectives
Subjects:	angioedema angiotensin-converting enzyme inhibitor ace inhibitor angiotensin receptor blocker arb
Online Access:	http://dx.doi.org/10.1080/20009666.2020.1711641

Similar Items

Drug-induced visceral angioedema
by: Prashanth M. Thalanayar, et al.
Published: (2014-09-01)

Bradykinin-Mediated Angioedema Induced by Commonly Used Cardiovascular Drugs
by: Janina Hahn, et al.
Published: (2023-09-01)

Five-Membered Nitrogen Heterocycles Angiotensin-Converting Enzyme (ACE) Inhibitors Induced Angioedema: An Underdiagnosed Condition
by: Niki Papapostolou, et al.
Published: (2024-03-01)

Valsartan/Sacubitril induced isolated angioedema of uvula: A case report
by: Maisa A. Nazzal, et al.
Published: (2024-11-01)

Is there a difference between an angiotensin-converting enzyme inhibitor and an angiotensin-specific receptor blocker for the treatment of hypertension?
by: James A. Ker
Published: (2015-05-01)

Tranexamic acid for angiotensin-converting enzyme inhibitor–induced angioedema
by: Gaurav Nitin Pathak, et al.
Published: (2024-03-01)

A rare presentation of angioedema with isolated retropharyngeal and supraglottic involvement
by: H. Patel, et al.
Published: (2019-01-01)

Hospitalizations due to Angioedema without Urticaria in a Portuguese Center: Five Year Retrospective Study
by: Joana Cosme, et al.
Published: (2019-11-01)

Clinical Features and Disease Course of Primary Angioedema Patients in a Tertiary Care Hospital
by: Pall AH, et al.
Published: (2020-07-01)

Case Report: Angiotensin converting enzyme inhibitors vs. angiotensin receptor blockers in the management of chronic hypertension: a case of lisinopril-induced rhinorrhea
by: Alice A. Amudzi, et al.
Published: (2024-11-01)

Critical angioedema induced by a renin angiotensin system blocker in the contemporary era of increasing heart failure: A case report and commentary
by: Masafumi Sato, et al.
Published: (2021-03-01)

Angiotensin-Converting Enzyme Inhibitor-Induced Gastrointestinal Angioedema: The First Danish Case Report
by: Marijana Rincic Antulov, et al.
Published: (2018-09-01)

Delayed angioedema during therapy with angiotensin-converting enzyme inhibitors
by: Janković Slobodan M., et al.
Published: (2011-01-01)

The dual blockade of the renin-angiotensin system in Internal Medicine: after ONTARGET trial
by: F. Rondoni, et al.
Published: (2013-05-01)

Over diagnosis of bradykinin angioedema in patients treated with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers
by: Marie Douillard, MD, et al.
Published: (2023-08-01)

Skin Reactions with Losartan and Enalapril in Cardiac Patients
by: Fariba Iraji, et al.
Published: (2012-03-01)

Impact of renin-angiotensin system inhibitors on the survival of patients with rectal cancer
by: Marcin Zeman, et al.
Published: (2022-07-01)

Spontaneous Epiretinal Membrane Resolution and Angiotensin Receptor Blockers: Case Observation, Literature Review and Perspectives
by: Filippo Confalonieri, et al.
Published: (2023-07-01)

Retrospective Evaluation of Patients with Angioedema Treated with C1 Inhibitors in an Emergency Department
by: Sercan Yalçınlı, et al.
Published: (2022-09-01)

Drugs acting on the renin–angiotensin–aldosterone system (RAAS) and deaths of COVID-19 patients: a systematic review and meta-analysis of observational studies
by: Ruchika Sharma, et al.
Published: (2022-09-01)

The Effect of ACE Inhibitors/ARBs Withdrawal on the Risk of Postoperative Complications in Abdominal Surgery
by: N. V. Trembach, et al.
Published: (2023-10-01)

Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19
by: Naci Şenkal, et al.
Published: (2020-07-01)

A Rare Case of Unilateral Tongue Edema with Angiotensin Converting Enzyme Inhibitors
by: Beatriz Gil Braga, et al.
Published: (2022-07-01)

Sacubitril/Valsartan vs ACE Inhibitors or ARBs
by: Endurance Evbayekha, MD, et al.
Published: (2025-03-01)

Acute angioedema in Cape Town emergency centres and a suggested algorithm to simplify and improve management
by: C Day, et al.
Published: (2023-08-01)

Association between types of antihypertensive medication and the risk of atrial fibrillation: a nationwide population study
by: JungMin Choi, et al.
Published: (2024-05-01)

Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors?
by: Elena Raccuglia, et al.
Published: (2009-11-01)

Endothelium a new target for a therapeutic action of ACE inhibitors
by: Yu A Karpov
Published: (2004-06-01)

Safety of ACE-I and ARB medications in COVID-19: A retrospective cohort study of inpatients and outpatients in California
by: Samuel J. S. Rubin, et al.
Published: (2021-01-01)

Real-world experience of angiotensin receptor-neprilysin inhibitors in patients with heart failure and dialysis
by: I-Ning Yang, et al.
Published: (2024-07-01)

ANALYSIS OF SERUM ANGIOTENSIN CONVERTING ENZYME (ACE) ACTIVITY ACROSS ACE GENOTPYE IN NEWLY DIAGNOSED HYPERTENSIVE PATIENTS
by: Digishaben D Patel, et al.
Published: (2017-06-01)

Angiotensin converting enzyme inhibitor-induced penile angioedema: A case report
by: Anthony Acosta, et al.
Published: (2025-03-01)

Proteinuria: pathophysiology, diagnostic and therapeutic approach
by: Enrico Valvo
Published: (2013-04-01)

Effect of sacubitril/valsartan and ACEI/ARB on glycaemia and the development of diabetes: a systematic review and meta-analysis of randomised controlled trials
by: Ruxin Wang, et al.
Published: (2022-12-01)

RAAS inhibitors are associated with a better chance of surviving of inpatients with Covid-19 without a diagnosis of diabetes mellitus, compared with similar patients who did not require antihypertensive therapy or were treated with other antihypertensives
by: Mykola Khalangot, et al.
Published: (2023-01-01)

Therapeutic Implications of Renin–Angiotensin System Modulators in Alzheimer’s Dementia
by: Daniela-Carmen Ababei, et al.
Published: (2023-09-01)

ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy
by: Zohreh Rahimi
Published: (2012-10-01)

ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?
by: K. A. Ghyamdzhyan, et al.
Published: (2022-12-01)

The role of renin-angiotensin system and angiotensin-converting enzyme 2 (ACE2) in the development and course of viral infection COVID-19 in patients with diabetes mellitus
by: O. K. Vikulova, et al.
Published: (2020-08-01)

Evaluation of the Association between Multilobar Involvement and ACE Inhibitor Use in SARS-CoV-2 Patients
by: Dilay Satilmis, et al.
Published: (2023-01-01)